Clinical Trials in Phoenix

Showing 5061-5080 of 16,646 trials

Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination for the Treatment of Allergic Conjunctivitis

NCT05579730

To evaluate the efficacy of Combo (Drug Product Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Ophthalmic Solution) compared to its individual components and vehicle in a population of subjects with allergic conjunctivitis:

Allergic Conjunctivitis

Bausch & Lomb Incorporated188 participantsStarted Oct 2022

Phoenix, Arizona, United States • Andover, Massachusetts, United States • Memphis, Tennessee, United States +1 more locations

COMPLETEDPhase 1/2< 1 mile

Myeloma-Developing Regimens Using Genomics (MyDRUG)

NCT03732703

The MyDRUG study is a type of Precision Medicine trial to treat patients with drugs targeted to affect specific genes that are mutated as part of the disease. Mutations in genes can lead to uncontrolled cell growth and cancer. Patients with a greater than 25% mutation to any of the following genes; CDKN2C, FGFR3, KRAS, NRAS, BRAF V600E, IDH2 or T(11;14) can be enrolled to one of the treatment arms. These arms have treatments specifically directed to the mutated genes. Patients that do not have a greater than 25% mutation to the genes listed can be enrolled to a non-actionable treatment arm. The genetic sequencing of the patient's tumor is required via enrollment to the MMRF002 study: Clinical-grade Molecular Profiling of Patients with Multiple Myeloma and Related Plasma Cell Malignancies. (NCT02884102).

Relapsed Refractory Multiple Myeloma

Multiple Myeloma Research Consortium103 participantsStarted Apr 2019

Phoenix, Arizona, United States • Duarte, California, United States • Atlanta, Georgia, United States +13 more locations

Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination for the Treatment of Allergic Conjunctivitis

Myeloma-Developing Regimens Using Genomics (MyDRUG)

Find Trials by Condition in Phoenix

A Phase 1b Study of Imvotamab in Moderate to Severe Rheumatoid Arthritis

A Study of Lithium and Enlicitide in Healthy Adult Participants (MK-0616-034)

Radium-223 Dichloride and Abiraterone Acetate Compared to Placebo and Abiraterone Acetate for Men With Cancer of the Prostate When Medical or Surgical Castration Does Not Work and When the Cancer Has Spread to the Bone, Has Not Been Treated With Chemotherapy and is Causing no or Only Mild Symptoms

A Study to Assess the Safety, Tolerability and Efficacy of IONIS-AGT-LRx in Hypertensive Participants With Uncontrolled Blood Pressure

A Study to Find Out How Different Forms of BIIB091 is Processed in The Body With and Without Food in Healthy Participants

Interventional Study of INCB 99280 With Ipilimumab in Participants With Select Solid Tumors

P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC)

BioProtect Balloon Implant™ Balloon System Pivotal Study BP-007

A Study Evaluating Safety and Tolerability, and Pharmacokinetics of Navitoclax Monotherapy and in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasm

A Study of KB-0742 in Participants With Relapsed or Refractory Solid Tumors Including Platinum Resistant High Grade Serous Ovarian Cancer (HGSOC)

Neuroblastoma Precision Trial

Study of Daily Application of Nestorone® (NES) and Testosterone (T) Combination Gel for Male Contraception

Safety and Effectiveness of the MiniMed™ 780G System With DS5 CGM

BP31510 (Ubidecarenone,USP) Nanosuspension for Intravenous Injection to Patients With Solid Tumors

Evaluation of the Safety and Effectiveness of Bilateral Exablate Ablation of the Pallidothalamic Tract (PTT) for the Treatment of the Motor Complications of Parkinson's Disease (PD)

A Study to Assess the Pharmacodynamics of VK0214 in Male Subjects With AMN

Mapping the Phenotype in Adults With Phelan-McDermid Syndrome

COVID-19 Vaccine Response in Sickle Cell Disease